학술논문
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program.
Document Type
Article
Author
Source
Clinical Trials; Jun2019, Vol. 16 Issue 3, p253-262, 10p, 1 Diagram, 2 Charts, 2 Graphs
Subject
Language
ISSN
17407745
Abstract
Copyright of Clinical Trials is the property of Sage Publications, Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)